About IGF Oncology

About company

IGF Oncology is a biotech company developing targeted anti-cancer chemotherapy drugs with better efficacy and lower side effects and, as compared to existing chemotherapy treatments. Their lead drug, IGF-MTX, targets the deadly blood cancer MDS, and is currently in clinical trials at the Mayo Clinic, and the results so far are excellent.